EI
Evolus Inc
🇩🇪XFRA.EVLGermanyHealthcare
€6.80EURup +0.10 (+1.49%)ClosedEnd of day9:47 PM
Price€6.80+0.10 (+1.49%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US30052C1071
- CUSIP
- Not reported
Company
- Employees
- 353
- Headquarters
- Newport Beach, United States
- Website
- https://www.evolus.com
- CEO
- Mr. David Moatazedi
Market
- Shares outstanding
- 65.9M
- Market cap
- €447.81M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
No high and low reported for today's session.
- Market cap
- €447.81M
- EPS LTM
- -$0.52calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $316.49M+13.87%up year on year
- Net income
- -$34.33M+44.62%up year on year
- Gross margin
- 66.25%-0.57%down year on year
- Free cash flow
- -$20.17M+58.19%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.